Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Regulation & Policy Market Research Reports

Titlepublishedprice

Global Big Pharma Partnering Terms and Agreements 2012-2018: Deal trends, players and financials

By Current Partnering
"...... > This report provides details of the latest Big Pharma agreements announced in the life sciences since 2012. The report takes the reader through a comprehensive review Big Pharma deal trends, key players, top deal values, as ......"
01-Apr-2018$2995

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

By Current Partnering
"...... s. This report provides details of the latest co-promotion and co-marketing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report covers details of co-promotion and co-m......"
01-Mar-2018$2995

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018

By Current Partnering
"...... es a detailed understanding and analysis of how and why companies enter business, royalty financing agreements. The focus of the report is on partnerships for royalty assets where partners have entered an agreement to dispose of or acq......"
01-Mar-2018$1995

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

By Current Partnering
"...... provides details of the latest joint venture agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of joint venture agreements from 2012. There is an increasing ......"
01-Mar-2018$1995

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2012 to 2018

By Current Partnering
"...... t provides details of the latest Co-development agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of Co-development agreements from 2012 to 2018. Th......"
01-Mar-2018$2995

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2018

By Current Partnering
"...... report provides details of the latest collaborative R&D deals announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date with the latest information, the report provides details of collaborative R&D deals from 2012 to 20......"
01-Mar-2018$2995

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2012-2018

By Current Partnering
"...... cal, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2012 to 2018. The report provides a detailed understanding and analysis of how and why companie......"
01-Mar-2018$2995

Partnerships, Licensing, Investments and M&A Deals and Trends for November 2017 in Pharmaceuticals

By GlobalData
"...... analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and......"
02-Jan-2018$1000

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - The Netherlands

By GlobalData
"...... an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the Netherlands. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and r......"
13-Dec-2017$1995

Partnerships, Licensing, Investments and M&A Deals and Trends for October 2017 in Pharmaceuticals

By GlobalData
"...... nalysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and v......"
08-Dec-2017$1000